NUVB - FDA clears Nuvation to begin Phase 1/2 study for oncology drug January, 08 2024 04:39 PM Nuvation Bio Inc. Class A 2024-01-08 16:39:14 ET More on Nuvation Bio Seeking Alpha’s Quant Rating on Nuvation Bio Historical earnings data for Nuvation Bio Financial information for Nuvation Bio For further details see: FDA clears Nuvation to begin Phase 1/2 study for oncology drug